172 related articles for article (PubMed ID: 27748759)
1. EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.
Wu J; Liu W; Williams JP; Ratner N
Oncogene; 2017 Mar; 36(12):1669-1677. PubMed ID: 27748759
[TBL] [Abstract][Full Text] [Related]
2. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.
Wu J; Keng VW; Patmore DM; Kendall JJ; Patel AV; Jousma E; Jessen WJ; Choi K; Tschida BR; Silverstein KA; Fan D; Schwartz EB; Fuchs JR; Zou Y; Kim MO; Dombi E; Levy DE; Huang G; Cancelas JA; Stemmer-Rachamimov AO; Spinner RJ; Largaespada DA; Ratner N
Cell Rep; 2016 Mar; 14(8):1979-90. PubMed ID: 26904939
[TBL] [Abstract][Full Text] [Related]
3. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
Elife; 2022 Mar; 11():. PubMed ID: 35311647
[TBL] [Abstract][Full Text] [Related]
4. Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
Li H; Zhao X; Yan X; Jessen WJ; Kim MO; Dombi E; Liu PP; Huang G; Wu J
Oncogene; 2016 Mar; 35(11):1468-74. PubMed ID: 26073082
[TBL] [Abstract][Full Text] [Related]
5. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.
Ling BC; Wu J; Miller SJ; Monk KR; Shamekh R; Rizvi TA; Decourten-Myers G; Vogel KS; DeClue JE; Ratner N
Cancer Cell; 2005 Jan; 7(1):65-75. PubMed ID: 15652750
[TBL] [Abstract][Full Text] [Related]
6. Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.
Williams JP; Wu J; Johansson G; Rizvi TA; Miller SC; Geiger H; Malik P; Li W; Mukouyama YS; Cancelas JA; Ratner N
Cell Stem Cell; 2008 Dec; 3(6):658-69. PubMed ID: 19041782
[TBL] [Abstract][Full Text] [Related]
7. Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma.
Wu J; Crimmins JT; Monk KR; Williams JP; Fitzgerald ME; Tedesco S; Ratner N
Am J Pathol; 2006 May; 168(5):1686-96. PubMed ID: 16651634
[TBL] [Abstract][Full Text] [Related]
8. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.
Choi K; Komurov K; Fletcher JS; Jousma E; Cancelas JA; Wu J; Ratner N
Sci Rep; 2017 Mar; 7():43315. PubMed ID: 28256556
[TBL] [Abstract][Full Text] [Related]
9. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J; Anastasaki C; Chen Z; Shipman T; Papke J; Yin K; Gutmann DH; Le LQ
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108355
[TBL] [Abstract][Full Text] [Related]
10. RUNX represses
Hall A; Choi K; Liu W; Rose J; Zhao C; Yu Y; Na Y; Cai Y; Coover RA; Lin Y; Dombi E; Kim M; Levanon D; Groner Y; Boscolo E; Pan D; Liu PP; Lu QR; Ratner N; Huang G; Wu J
Sci Adv; 2019 Apr; 5(4):eaau8389. PubMed ID: 31032403
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
12. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Fletcher JS; Springer MG; Choi K; Jousma E; Rizvi TA; Dombi E; Kim MO; Wu J; Ratner N
Oncogene; 2019 Apr; 38(15):2876-2884. PubMed ID: 30542122
[TBL] [Abstract][Full Text] [Related]
13. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.
Muir D; Neubauer D; Lim IT; Yachnis AT; Wallace MR
Am J Pathol; 2001 Feb; 158(2):501-13. PubMed ID: 11159187
[TBL] [Abstract][Full Text] [Related]
14. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.
Rhodes SD; He Y; Smith A; Jiang L; Lu Q; Mund J; Li X; Bessler W; Qian S; Dyer W; Sandusky GE; Horvai AE; Armstrong AE; Clapp DW
Hum Mol Genet; 2019 Aug; 28(16):2752-2762. PubMed ID: 31091306
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
16. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal Loss of
Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
[TBL] [Abstract][Full Text] [Related]
19. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.
Wu J; Williams JP; Rizvi TA; Kordich JJ; Witte D; Meijer D; Stemmer-Rachamimov AO; Cancelas JA; Ratner N
Cancer Cell; 2008 Feb; 13(2):105-16. PubMed ID: 18242511
[TBL] [Abstract][Full Text] [Related]
20. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
